26 results on '"Greten J"'
Search Results
2. Checkpoint acupuncture as a novel complementary tool to address postoperative pain within the ERAS®-pathway for abdominal surgery
- Author
-
Ghanad, E., primary, Yang, C., additional, Weiß, C., additional, Machado, J., additional, Goncalves, M., additional, Otto, M., additional, Reißfelder, C., additional, Greten, J., additional, and Herrle, F., additional
- Published
- 2022
- Full Text
- View/download PDF
3. Pain therapy within the ERAS concept – Creating objectivity in studies on personalized checkpoint acupuncture
- Author
-
Ghanad, E., primary, Machado, J., additional, Santos, M.J., additional, Goncalves, M., additional, Reißfelder, C., additional, Herrle, F., additional, and Greten, J., additional
- Published
- 2022
- Full Text
- View/download PDF
4. The effect of checkpoint acupuncture on postoperative pain after abdominal surgery: A controlled pilot study in an ERAS®-setting
- Author
-
Staff, S., primary, Yang, C., additional, Ghanad, E., additional, Greten, J., additional, Otto, M., additional, Weiß, C., additional, Reißfelder, C., additional, and Herrle, F., additional
- Published
- 2022
- Full Text
- View/download PDF
5. Relevance of laser irradiance threshold in the induction of alkaline phosphatase in human osteoblast cultures
- Author
-
Haxsen, V., Schikora, D., Sommer, U., Remppis, A., Greten, J., and Kasperk, C.
- Published
- 2008
- Full Text
- View/download PDF
6. Acupuncture treatment improves nerve conduction in peripheral neuropathy
- Author
-
Schröder, S., Liepert, J., Remppis, A., and Greten, J. H.
- Published
- 2007
7. Stimulation of acupoint ST-34 acutely improves gait performance in geriatric patients during rehabilitation: A randomized controlled trial
- Author
-
Hauer, K., Wendt, I., Schwenk, M., Rohr, C., Oster, P., Greten, J., and Karstens, Sven
- Published
- 2011
- Full Text
- View/download PDF
8. Expression of Receptors for Advanced Glycation End Products in Peripheral Occlusive Vascular Disease
- Author
-
Ritthaler, U., Deng, Y., Zhang, Y., Greten, J., Abel, M., Sido, B., Allenberg, J., Otto, G., Roth, H., Bierhaus, A., Ziegler, R., Schmidt, A.-M., Waldherr, R., Wahl, P., Stern, D. M., and Nawroth, P. P.
- Subjects
Adult ,Aged, 80 and over ,endocrine system diseases ,Receptor for Advanced Glycation End Products ,Middle Aged ,Muscle, Smooth, Vascular ,Reference Values ,cardiovascular system ,Immunologic Techniques ,Humans ,RNA, Messenger ,Vascular Diseases ,Antigens ,Receptors, Immunologic ,In Situ Hybridization ,Regular Articles ,Aged - Abstract
The cellular interactions of advanced glycation end products (AGEs), which have been hypothesized to contribute to the development of vascular lesions, occur, at least in part, through their binding to a novel integral membrane protein, the receptor for AGEs (RAGE). Studies of human vascular segments show that endothelial RAGE expression at the antigen and mRNA level was variable and usually at low levels in samples from healthy individuals. In contrast, patients with a range of peripheral occlusive vascular diseases, with or without underlying diabetes, demonstrated prominent enhancement of endothelial RAGE expression. Smooth muscle cells and nerves in the vessel wall showed constitutively high levels of RAGE expression that were unchanged with aging (from 1 to 92 years) or by the presence of vascular disease. These data suggest that RAGE is likely to have ligands other than AGEs, and that multiple factors in addition to AGEs impact on its expression. Taken together, our findings suggest that RAGE may contribute to the pathogenesis of a range of vascular disorders.
- Published
- 1995
9. Relevance of laser irradiance threshold in the induction of alkaline phosphatase in human osteoblast cultures
- Author
-
Haxsen, V., primary, Schikora, D., additional, Sommer, U., additional, Remppis, A., additional, Greten, J., additional, and Kasperk, C., additional
- Published
- 2007
- Full Text
- View/download PDF
10. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma.
- Author
-
Zhang, Y, primary, Deng, Y, additional, Wendt, T, additional, Liliensiek, B, additional, Bierhaus, A, additional, Greten, J, additional, He, W, additional, Chen, B, additional, Hach-Wunderle, V, additional, Waldherr, R, additional, Ziegler, R, additional, Männel, D, additional, Stern, D M, additional, and Nawroth, P P, additional
- Published
- 1996
- Full Text
- View/download PDF
11. Receptors for advanced glycation end-products (AGE)--expression by endothelial cells in non-diabetic uraemic patients
- Author
-
Greten, J., primary, Kreis, I., additional, Wiesel, K., additional, Stier, E., additional, Schmidt, A. M., additional, Stern, D. M., additional, Ritz, E., additional, Waldherr, R., additional, and Nawroth, P. P., additional
- Published
- 1996
- Full Text
- View/download PDF
12. Expression of receptors for advanced glycosylated end-products in renal disease.
- Author
-
Abel, M., Ritthaler, U., Zhang, Y., Deng, Y., Schmidt, A. M., Greten, J., Sernau, T., Wahl, P., Andrassy, K., Ritz, E., Waldherr, R., Stern, D. M., and Nawroth, P. P.
- Published
- 1995
13. Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor.
- Author
-
Bierhaus, A, Zhang, Y, Deng, Y, Mackman, N, Quehenberger, P, Haase, M, Luther, T, Müller, M, Böhrer, H, and Greten, J
- Abstract
This study examines the regulation of the human tissue factor (TF) promotor in vitro and in vivo. Transient transfections were performed in bovine aortic endothelial cells to investigate the role of two fundamentally different AP-1 sites and a closely located NF-kappa B site in the human TF promoter. The NF-kappa B site is functionally active, since overexpression of NF-kappa B(p65) resulted in induction of TF mRNA and activity. Promoter analysis showed that NF-kappa B induction was dependent on the integrity of the region from base pair -188 to -181. Over-expression of Jun/Fos resulted in TF induction of transcription and protein/activity. Functional studies revealed that the proximal AP-1 site, but not the distal, was inducible by Jun/Fos heterodimers. The distal AP-1 site, which has a G-->A switch at position 4, was inductible by Jun homodimers. Electrophoretic mobility shift assays, using extracts of tumor necrosis factor alpha (TNF alpha)-stimulated bovine aortic endothelial cells, demonstrated TNF alpha-inducible binding to the proximal AP-1 site, comprising JunD/Fos heterodimers. At the distal AP-1 site, only minor induction of binding activity, characterized as proteins of the Jun and ATF family, was observed. Consistently, this site only marginally participates in TNF alpha induction. Functional studies with TF promotor plasmids confirmed that deletion of the proximal AP-1 or the NF-kappa B site decreased TNF alpha-mediated TF induction to a higher extend than loss of the distal AP-1 site. However, integrity of both AP-1 sites and the NF-kappa B site was required for optimal TNF alpha stimulation. The relevance of these in vitro data was confirmed in vivo in a mouse tumor model. Expression plasmids for a dominant negative Jun mutant or I-kappa B were packaged in liposomes. When either mutated Jun or I-kappa B were injected intravenously 48 h before TNF alpha, a reduction in TNF alpha-mediated TF expression in the tumor endothelial cells was observed. Simultaneously, fibrin/fibrinogen deposition decreased and free blood flow could be restored. Thus, TNF alpha-induced up-regulation of endothelial cell TF depends on a concerted action of members of the bZIP and NF-kappa B family.
- Published
- 1995
14. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products
- Author
-
Greten Johannes, Weichenhan Dieter, Most Patrick, Bierhaus Angelika, Eggers Kai, Ehlermann Philipp, Nawroth Peter P, Katus Hugo A, and Remppis Andrew
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Summary Background Atherosclerosis is an inflammatory disease in which a perpetuated activation of NFkappaB via the RAGE (receptor for advanced glycation end products)-MAPK signalling pathway may play an important pathogenetic role. As recently S100 proteins have been identified as ligands of RAGE, we sought to determine the effects of the proinflammatory heterodimer of S100A8/S100A9 on the RAGE-NFkappaB mediated induction of proinflammatory gene expression. Methods Human umbilical vein endothelial cells (HUVEC) were preincubated for 72 h with AGE-albumin or unmodified albumin for control, whereas AGE-albumin induction resulted in an upregulation of RAGE. Following this preactivation, cells were stimulated for 48 h with heterodimeric human recombinant S100A8/S100A9. Results Heterodimeric S100A8/S100A9 enhanced secretion of IL-6, ICAM-1, VCAM-1 and MCP1 in AGE-albumin pretreated HUVEC in a dose dependent manner. These effects could not be detected after stimulation with the homodimeric proteins S100A8, S100A9, S100A1 and S100B. The effects of heterodimeric S100A8/S100A9 were reduced by inhibition of the MAP-kinase pathways ERK1/2 and p38 by PD 98059 and SB 203580, respectively. Conclusion The heterodimeric S100A8/S100A9 might therefore play a hitherto unknown role in triggering atherosclerosis in diabetes and renal failure, pathophysiological entities associated with a high AGE burden. Thus, blocking heterodimeric S100A8/S100A9 might represent a novel therapeutic modality in treating atherosclerosis.
- Published
- 2006
- Full Text
- View/download PDF
15. Manual Acupuncture for Postoperative Pain and Recovery after Abdominal Surgeries: A Systematic Review.
- Author
-
Staff S, Yang C, Greten J, Braun V, Reissfelder C, Herrle F, and Ghanad E
- Abstract
Introduction: Acupuncture's role in surgical and postoperative contexts is gaining traction. However, the evidence remains patchy and is often of low-grade quality, particularly in the context of postintestinal surgery. Purpose: To assess acupuncture's efficacy in pain relief and functional recovery after abdominal surgery. Methods: We searched PubMed, Cochrane, Web of Science, and Google Scholar for randomized trials using manual acupuncture as the main intervention. Outcomes included postoperative pain, analgesic use, nausea, gastrointestinal (GI) regeneration, and length of hospital stay. For risk of bias assessment Cochrane risk of bias tool 2 was employed. Registered with PROSPERO: CRD42022311718. Results: Of 700 records till May 2023, 8 trials (551 patients; 16-200/trial) were included. Due to factors such as varying experimental settings and unpublished protocols, there was high risk of bias and heterogeneity, making meta-analysis unfeasible. Safety data were documented sufficiently by two trials. However, acupuncture showed marked benefits in pain relief, less analgesic use, fewer nausea cases, and improved GI recovery. One study reported reduced hospitalization time. Conclusion: Due to the varied methodologies and potential biases in existing studies, the definitive effectiveness of acupuncture remains unclear. To confirm the potential benefits of acupuncture as suggested by the reviewed studies, it's imperative to have more standardized study protocols, well-defined interventions and controls, and objective measures of efficacy.
- Published
- 2024
- Full Text
- View/download PDF
16. Electrophysiologically verified effects of acupuncture on diabetic peripheral neuropathy in type 2 diabetes: The randomized, partially double-blinded, controlled ACUDIN trial.
- Author
-
Meyer-Hamme G, Friedemann T, Greten J, Gerloff C, and Schroeder S
- Subjects
- Action Potentials, Acupuncture Therapy adverse effects, Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2 diagnosis, Diabetic Neuropathies diagnosis, Diabetic Neuropathies etiology, Diabetic Neuropathies physiopathology, Double-Blind Method, Female, Germany, Humans, Male, Middle Aged, Neural Conduction, Neurologic Examination, Patient Reported Outcome Measures, Prospective Studies, Time Factors, Treatment Outcome, Acupuncture Therapy instrumentation, Diabetes Mellitus, Type 2 complications, Diabetic Neuropathies therapy, Lasers adverse effects, Peripheral Nerves physiopathology
- Abstract
Background: Acupuncture is commonly used in Traditional Chinese Medicine for treatment of diabetic peripheral neuropathy (DPN), but data from randomized controlled trials are rare., Methods: This randomized, placebo-controlled, partially double-blinded clinical trial randomly assigned adults with confirmed type 2 diabetes-induced DPN to receive 10 sessions of needle acupuncture, laser acupuncture, or placebo laser acupuncture for 10 consecutive weeks. Treatment was provided at bilateral acupoints Ex-LE-10 (Bafeng), Ex-LE-12 (Qiduan), and ST-34 (Lianqiu). Neurological assessments, including nerve conduction studies (NCS) of sural and tibial nerves, were performed at baseline and weeks 6 and 15. Primary outcome was delta of sural sensory nerve action potential (SNAP). Secondary outcomes included further NCS values, clinical scores, and patient-reported outcome measures (PROMs)., Results: Of 180 participants, 172 completed the study. Sural SNAP and sural and tibial nerve conduction velocities improved significantly after 10 treatments when comparing needle acupuncture to placebo. Needle acupuncture showed earlier onset of action than laser acupuncture. PROMs showed larger improvements following needle and laser acupuncture than placebo, reaching significant differences for hyperesthesia and cramps following needle acupuncture and for heat sensation following laser acupuncture., Conclusions: Classical needle acupuncture had significant effects on DPN. Improvement in NCS values presumably indicates structural neuroregeneration following acupuncture., (© 2020 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
17. Stimulation of acupoint ST-34 acutely improves gait performance in geriatric patients during rehabilitation: A randomized controlled trial.
- Author
-
Hauer K, Wendt I, Schwenk M, Rohr C, Oster P, and Greten J
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Walking, Acupuncture Therapy methods, Frail Elderly, Gait
- Abstract
Objective: To determine whether a specific regimen of acupoint stimulation improved gait performance in geriatric patients., Design: Multiple-blinded, randomized, controlled intervention trial., Setting: Geriatric ward rehabilitation., Participants: 60 geriatric patients during rehabilitation., Interventions: Both groups received a 1-time acupoint stimulation according to randomization. Stimulation of a verum acupoint (verum treatment) according to principles of traditional Chinese medicine was compared with a technically identical needle application on a nonacupoint (control treatment) in the control group., Main Outcome Measures: Descriptive parameters were documented by valid, established tests. Gait performance was objectively measured by an electronic walkway before needling and after needling., Results: All gait parameters showed statistically significant improvement after verum treatment compared with control treatment (velocity, cadence, stride length, cycle time, step time, single support, double support: P values all <.05) except for the base of support (P=.163). Effect sizes achieved by 1-time stimulation of an acupoint were low and ranged from .08 to .24. No severe adverse clinical events related to the intervention occurred., Conclusions: Study results showed that a 1-time administration of a specific acupoint stimulation regimen statistically significantly improved gait performance during geriatric ward rehabilitation. If sustainability of effects can be documented, acupuncture may prove to be an inexpensive intervention that may mildly improve motor performance in frail geriatric patients., (Copyright © 2011 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
18. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NFkappaB.
- Author
-
Freudlsperger C, Greten J, and Schumacher U
- Subjects
- Cell Growth Processes drug effects, Cell Line, Tumor, Child, Preschool, Dose-Response Relationship, Drug, Female, HL-60 Cells, Humans, Infant, Male, NF-kappa B biosynthesis, Neuroblastoma metabolism, Neuroblastoma pathology, Apoptosis drug effects, Curcumin pharmacology, NF-kappa B antagonists & inhibitors, Neuroblastoma drug therapy
- Abstract
Background: Metastasised neuroblastoma is a largely incurable neoplasia in children over one year of age using current treatment protocols. After dissemination to the bone, the survival rate is <7%, indicating an urgent need for novel therapeutic regimes. As curcumin (diferuloylmethane) had been shown to exert strong anticancer effects against diverse human malignancies different from neurblastoma, the antiproliferative effect of curcumin on the growth of human neuroblastoma cell lines was tested., Materials and Methods: Proliferation of neuroblastoma cell lines Lan-5, SK-N-SH and Kelly under the treatment of curcumin over a broad concentration range (1 x 10(-5) to 1 x 10(2) microM) was assessed using XTT cell proliferation assays. Possible induction of apoptosis through curcumin treatment was assessed by detection of DNA fragmentation. To investigate the effect of curcumin on NFkappaB activation, the protein levels of the NFkappaB subunit p65 of curcumin-treated cells were compared to untreated cells using Western blots., Results: Curcumin showed a significant dose-dependent antiproliferative effect on all three neuroblastoma cell lines starting at a concentration of 1 x 10(-3) microM. The highest concentration of 1 x 10(2) microM significantly reduced the viable cell count to 8-48% depending on the cell line. This antiproliferative effect was mediated through an increased induction of apoptosis by inhibition of NFkappaB, corroborating earlier findings indicating an antiapoptotic effect of NFkappaB., Conclusion: Our results suggest that curcumin might hold promise in the treatment of patients suffering from neuroblastoma.
- Published
- 2008
19. Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels.
- Author
-
Kelemen K, Kiesecker C, Zitron E, Bauer A, Scholz E, Bloehs R, Thomas D, Greten J, Remppis A, Schoels W, Katus HA, and Karle CA
- Subjects
- Animals, Catechin administration & dosage, Cells, Cultured, Dose-Response Relationship, Drug, ERG1 Potassium Channel, Ether-A-Go-Go Potassium Channels drug effects, Ion Channel Gating drug effects, Kidney drug effects, Oocytes drug effects, Xenopus laevis, Catechin analogs & derivatives, Ether-A-Go-Go Potassium Channels physiology, Ion Channel Gating physiology, Kidney physiology, Oocytes physiology, Potassium metabolism, Tea chemistry
- Abstract
The catechin EGCG is the main flavonoid compound of green tea and has received enormous pharmacological attention because of its putative beneficial health effects. This study investigated for the first time the effect of EGCG on hERG channels, the main pharmacological target of drugs that cause acquired long QT syndrome. Cloned hERG channels were expressed in Xenopus oocytes and in HEK293 cells. Heterologous hERG currents were inhibited by EGCG with an IC50 of 6.0 micromol/l in HEK293 cells and an IC50 of 20.5 micromol/l in Xenopus laevis oocytes. Onset of effect was slow and only little recovery from inhibition was observed upon washout. In X. laevis oocytes EGCG inhibited hERG channels in the open and inactivated states, but not in the closed states. The half-maximal activation voltage of hERG currents was shifted by EGCG towards more positive potentials. In conclusion, EGCG is a low-affinity inhibitor of hERG sharing major electrophysiological features with pharmaceutical hERG antagonists.
- Published
- 2007
- Full Text
- View/download PDF
20. Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656.
- Author
-
Scholz EP, Zitron E, Kiesecker C, Thomas D, Kathöfer S, Kreuzer J, Bauer A, Katus HA, Remppis A, Karle CA, and Greten J
- Subjects
- Amino Acids, Aromatic genetics, Animals, Dose-Response Relationship, Drug, ERG1 Potassium Channel, Hesperidin chemistry, Hesperidin metabolism, Mutation physiology, Oocytes drug effects, Patch-Clamp Techniques, Potassium Channel Blockers metabolism, Xenopus, Amino Acids, Aromatic metabolism, Cardiovascular Diseases prevention & control, Citrus sinensis chemistry, Ether-A-Go-Go Potassium Channels drug effects, Hesperidin pharmacology, Potassium Channel Blockers pharmacology
- Abstract
Background and Aims: Hesperetin belongs to the flavonoid subgroup classified as citrus flavonoids and is the main flavonoid in oranges. A high dietary intake of flavonoids has been associated with a significant reduction in cardiovascular mortality. HERG potassium channels play a major role in cardiac repolarisation and represent the most important pharmacologic target of both antiarrhythmic and proarrhythmic drugs., Methods and Results: We used the two-microelectrode voltage-clamp technique to analyse inhibitory effects of hesperetin on hERG potassium channels heterologously expressed in Xenopus oocytes. Hesperetin blocked hERG potassium channels in a concentration dependent manner. Onset of block was fast and completely reversible upon wash-out. There was no significant effect of hesperetin on channel kinetics. Affinity of hesperetin to mutant F656A hERG channel was significantly decreased compared to WT hERG, indicating a binding site in the channel pore cavity. In contrast, affinity of hesperetin to Y652A hERG was not different from the affinity to WT hERG., Conclusion: We found an antagonist of cardiac hERG channels that modulates hERG currents by accessing the aromatic pore binding site, particularly amino acid phe-656. Regarding high hesperetin concentrations found in oranges and the increasing consumption of oranges and orange juice in Europe, potential effects of hesperetin on cardiac electrophysiology in vivo deserve further investigation.
- Published
- 2007
- Full Text
- View/download PDF
21. In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform.
- Author
-
Scholz EP, Alter M, Zitron E, Kiesecker C, Kathöfer S, Thomas D, Kreye VA, Kreuzer J, Becker R, Katus HA, Greten J, and Karle CA
- Subjects
- Animals, Cell Line, Dose-Response Relationship, Drug, Ether-A-Go-Go Potassium Channels antagonists & inhibitors, Female, Kidney drug effects, Kidney embryology, Membrane Potentials drug effects, Oocytes drug effects, Patch-Clamp Techniques, Tachycardia, Ventricular metabolism, Xenopus laevis, Chloroform toxicity, Ether-A-Go-Go Potassium Channels metabolism, Solvents toxicity, Tachycardia, Ventricular chemically induced
- Abstract
Acute chloroform intoxication can cause depression of the central nervous system and may lead to death from lethal arrhythmias or respiratory arrest. Thus, the organic solvent is no longer in clinical use as an anaesthetic, but still plays a role in cases of suicide, homicide or inhalation for psychotropic effects. Several cases of lethal arrhythmia after intoxication with chloroform have been described. Pharmacological inhibition of cardiac "human ether-à-go-go-related gene" (HERG) potassium channels is linked to proarrhythmic effects of cardiac and noncardiac drugs. To further investigate the electrophysiological basis of the arrhythmogenic potential of chloroform, we analysed inhibitory effects of chloroform on cloned HERG potassium channels, heterologously expressed in Xenopus oocytes and in Human Embryonic Kidney (HEK 293) cells using the double-electrode voltage-clamp technique and the whole-cell patch-clamp technique, respectively. In HEK cells, chloroform blocked HERG tail currents with an IC(50) of 4.97mM. Biophysical properties were further investigated in the Xenopus oocyte expression system. Onset and wash-out of block was fast and inhibition was completely reversible. Chloroform did not alter channel activation, however, direct channel inactivation was accelerated significantly. Steady-state-inactivation of HERG was not affected. Chloroform dependent block of HERG channels was voltage dependent with a decrease of inhibition at more positive membrane potentials. No frequency-dependence of block could be observed. In summary, chloroform blocked HERG potassium channels probably in a toxicologically relevant concentration. These findings contribute to the pathophysiology of proarrhythmic effects in acute chloroform intoxication.
- Published
- 2006
- Full Text
- View/download PDF
22. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
- Author
-
Ehlermann P, Eggers K, Bierhaus A, Most P, Weichenhan D, Greten J, Nawroth PP, Katus HA, and Remppis A
- Subjects
- Calgranulin B pharmacology, Cells, Cultured, Chemokine CCL2 metabolism, Dimerization, Dose-Response Relationship, Drug, Endothelium, Vascular physiopathology, Humans, Intercellular Adhesion Molecule-1 metabolism, Interleukin-6 metabolism, Mitogen-Activated Protein Kinases antagonists & inhibitors, Recombinant Proteins, Umbilical Veins, Vascular Cell Adhesion Molecule-1 metabolism, Calgranulin A physiology, Calgranulin B physiology, Endothelium, Vascular drug effects, Glycation End Products, Advanced pharmacology, Inflammation physiopathology
- Abstract
Background: Atherosclerosis is an inflammatory disease in which a perpetuated activation of NFkappaB via the RAGE (receptor for advanced glycation end products)-MAPK signalling pathway may play an important pathogenetic role. As recently S100 proteins have been identified as ligands of RAGE, we sought to determine the effects of the proinflammatory heterodimer of S100A8/S100A9 on the RAGE-NFkappaB mediated induction of proinflammatory gene expression., Methods: Human umbilical vein endothelial cells (HUVEC) were preincubated for 72 h with AGE-albumin or unmodified albumin for control, whereas AGE-albumin induction resulted in an upregulation of RAGE. Following this preactivation, cells were stimulated for 48 h with heterodimeric human recombinant S100A8/S100A9., Results: Heterodimeric S100A8/S100A9 enhanced secretion of IL-6, ICAM-1, VCAM-1 and MCP1 in AGE-albumin pretreated HUVEC in a dose dependent manner. These effects could not be detected after stimulation with the homodimeric proteins S100A8, S100A9, S100A1 and S100B. The effects of heterodimeric S100A8/S100A9 were reduced by inhibition of the MAP-kinase pathways ERK1/2 and p38 by PD 98059 and SB 203580, respectively., Conclusion: The heterodimeric S100A8/S100A9 might therefore play a hitherto unknown role in triggering atherosclerosis in diabetes and renal failure, pathophysiological entities associated with a high AGE burden. Thus, blocking heterodimeric S100A8/S100A9 might represent a novel therapeutic modality in treating atherosclerosis.
- Published
- 2006
- Full Text
- View/download PDF
23. Localisation of protein Z in vascular lesions of patients with atherosclerosis.
- Author
-
Greten J, Kreis I, Liliensiek B, Allenberg J, Amiral J, Ziegler R, and Nawroth PP
- Subjects
- Arterial Occlusive Diseases pathology, Diabetic Angiopathies pathology, Humans, Microcirculation pathology, Arteriosclerosis pathology, Blood Proteins analysis, Endothelium, Vascular pathology
- Abstract
Background: The deposition of protein Z was investigated in atherosclerotic vascular lesions of patients with diabetes mellitus or atherosclerotic vascular disease without diabetes in comparison to controls., Patients and Methods: Protein Z antigen was evidenced by immunohistochemistry in arteries of 5 healthy control patients, 11 diabetic patients with arterio-occlusive disease and 7 patients suffering from arterio-occlusive disease without diabetes. For immunohistochemistry, a commercially available antibody was taken as first antibody, and immunopositivity was evaluated independently by two investigators (J.G.; I.K.) as negative (0), positive (+) and strongly positive (++). The results were assessed by the Whitney-Mann-Wilcoxon test., Results: Macrovascular endothelial cells were stained positive for protein Z in all arteries studied. Arteries of controls did not show significant immunopositivity in cells other than macrovascular endothelial cells, while the microvascular endothelial cells of control arteries were largely negative. The proliferating subendothelial space in atherosclerotic vascular lesions showed significant immunopositivity for protein Z. In contrast to control arteries, the microvascular endothelial cells of the proliferating areas stained positive. The staining pattern of the subendothelial space was similar in atherosclerotic vessels independent of the risk factor for atherosclerosis. Plaques were immunopositive for protein Z, too., Conclusions: Protein Z is present in atherosclerotic vascular lesions of diabetic and non-diabetic patients, but not in the subendothelial space and microvascular endothelial cells of healthy controls. Since protein Z-positivity was detected in microvascular endothelium as well as in extra-vascular deposits around plaques, it may play a role in the development of these lesions.
- Published
- 1998
24. Prothrombin complex concentrate contains protein Z and prevents bleeding in a patient with protein Z deficiency.
- Author
-
Greten J, Kemkes-Matthes B, and Nawroth PP
- Subjects
- Blood Proteins analysis, Blood Proteins deficiency, Humans, Prothrombin chemistry, Blood Proteins therapeutic use, Hemorrhage prevention & control, Prothrombin therapeutic use
- Published
- 1995
25. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease.
- Author
-
Ritthaler U, Deng Y, Zhang Y, Greten J, Abel M, Sido B, Allenberg J, Otto G, Roth H, and Bierhaus A
- Subjects
- Adult, Aged, Aged, 80 and over, Antigens metabolism, Humans, Immunologic Techniques, In Situ Hybridization, Middle Aged, Muscle, Smooth, Vascular cytology, Muscle, Smooth, Vascular metabolism, RNA, Messenger metabolism, Receptor for Advanced Glycation End Products, Receptors, Immunologic genetics, Receptors, Immunologic immunology, Reference Values, Vascular Diseases pathology, Receptors, Immunologic metabolism, Vascular Diseases metabolism
- Abstract
The cellular interactions of advanced glycation end products (AGEs), which have been hypothesized to contribute to the development of vascular lesions, occur, at least in part, through their binding to a novel integral membrane protein, the receptor for AGEs (RAGE). Studies of human vascular segments show that endothelial RAGE expression at the antigen and mRNA level was variable and usually at low levels in samples from healthy individuals. In contrast, patients with a range of peripheral occlusive vascular diseases, with or without underlying diabetes, demonstrated prominent enhancement of endothelial RAGE expression. Smooth muscle cells and nerves in the vessel wall showed constitutively high levels of RAGE expression that were unchanged with aging (from 1 to 92 years) or by the presence of vascular disease. These data suggest that RAGE is likely to have ligands other than AGEs, and that multiple factors in addition to AGEs impact on its expression. Taken together, our findings suggest that RAGE may contribute to the pathogenesis of a range of vascular disorders.
- Published
- 1995
26. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart.
- Author
-
Remppis A, Scheffold T, Greten J, Haass M, Greten T, Kübler W, and Katus HA
- Subjects
- Animals, Biological Transport, Cell Compartmentation, In Vitro Techniques, Male, Rats, Rats, Wistar, Reperfusion Injury pathology, Troponin T, Calcium metabolism, Reperfusion Injury metabolism, Troponin metabolism
- Abstract
The marked differences in troponin T serum concentrations observed in patients with reperfused and non-reperfused myocardial infarction may be due to a perfusion dependent wash-out of an unbound fraction of cardiac troponin T. To test the release kinetics of troponin T experimentally, the isolated rat heart (Langendorff preparation) was damaged either by the calcium paradox or by no-flow ischemia. Following membrane damage by the calcium paradox troponin T (TNT) showed the same release kinetics in the coronary effluent as the cytosolic markers creatine kinase (CK) or lactate dehydrogenase (LDH). Peak levels of troponin T (282 +/- 58 micrograms/l), CK (6754 +/- 1642 U/l), and LDH (5817 +/- 1730 U/l) occurred 5 min after onset of reperfusion with calcium containing buffers and returned to 9.9%, 1.3%, and 1% of their respective peak levels within 55 min of reperfusion. During reperfusion after no-flow ischemia different release kinetics were found for cytosolic enzymes and troponin T. After 60 min of ischemia, troponin T levels in the coronary effluent increased over the entire reperfusion period of 55 min, almost doubling the 5 min value (191%). In contrast, cardiac enzymes rapidly declined to 18% (CK) and 23% (LDH) of their respective 5 min values at the end of reperfusion. Light microscopy after reperfusion with carbon black revealed a complete and homogeneous reperfusion of Langendorff hearts after no-flow ischemia. Immunoblot analysis confirmed the release of an undegraded 39 kDa troponin T molecule, both after global ischemia and the calcium paradox. These data indicate that prolonged ischemia induces a continuous liberation of cardiac troponin T, most probably from disintegrating myofibres, whereas membrane damage leads almost exclusively to leakage of a functionally unbound troponin T pool. These findings may explain the biphasic serum concentration changes of cardiac troponin T in patients with reperfused myocardial infarction.
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.